2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1730296328 MD
Verify on CMS →

MERYL REICHMAN, MD

Endocrinology, Diabetes & Metabolism Physician in FISHKILL, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
5K
Medicare Part D claims · 413 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
51%
generic claims · 49% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
59.9008/100
▼ 23 pts below national avg 83.1 · [object Object]

What the federal data shows

MERYL REICHMAN, MD reported a CMS MIPS final score of 59.9008/100 — below the 83.1 national average — and filed 4,838 Medicare Part D claims in 2023.

59.9008/100
MIPS score · -23 vs avg
5K
Part D claims, 2023
51%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MERYL REICHMAN, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

60 5th percentile higher than 5% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). This entry sits in this band. 60–70: 13,906 scored providers (3%). Above this entry. 70–80: 118,074 scored providers (25%). Above this entry. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

MERYL REICHMAN, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MERYL REICHMAN, MD?

Below national average

NPI registry status

Active

Issued 08/23/2006

NPI 1730296328

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

4,838 83% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

MIPS final score

59.9008/100 23.199199999999998% pts

Mid-tier band

vs 83.1 national avg

Specialty distribution in New York

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among New York providers

New York providers

Endocrinology, Diabetes & Metabolism Physician share within New York

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within New York

Medicare quality performance — MIPS

MERYL REICHMAN, MD's 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average

Below national average
MIPS Final Score
59.9008/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 59.9008/100 vs national avg 83.1

0%100%National avg83%59.9%
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 59.9008/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MERYL REICHMAN, MD appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding MD credentials at 600 WESTAGE BUSINESS CTR DR, FISHKILL, NY, 12524, with a listed phone of (845) 231-5600. NPI 1730296328 was issued on 08/23/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what REICHMAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 4,838 prescription claims written by this provider, covering 413 Medicare beneficiaries and totaling roughly $2.5 million in drug spend, split 49% brand-name and 51% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 59.9008/100 for the 2023 performance year (Quality 23.9172, Cost 60.752), compared with the national average of 83.1.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

600 WESTAGE BUSINESS CTR DR
FISHKILL, NY 12524

Provider Details

NPI 1730296328
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials MD
Gender Female
NPI Issued 08/23/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

59.9008
Final Score
Avg: 83.1
23.9172
Quality
60.752
Cost
88
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where MERYL REICHMAN, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

DAY KIMBALL MEDICAL GROUP INC
PUTNAM, CT

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to MERYL REICHMAN, MD. To verify MERYL REICHMAN, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

MERYL REICHMAN, MD — brand share 49.0%
Specialty average (est.)

49% brand-name claims vs 51% generic, on 4,838 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

4,838
Total Claims
$2.5M
Total Drug Cost
413
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
9,477
Total Day Supply
277,245
Brand vs Generic
49% brand / 51% generic
Brand Drug Cost
$2.3M
Generic Drug Cost
$66K
Antibiotic Claims
30

Patient Demographics

Average Patient Age
69.2 years
Avg HCC Risk Score
1.70
Gender Split
64% female / 36% male
Age Distribution
<65: 95, 65-74: 195, 75-84: 106, 85+: 17

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MERYL REICHMAN, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Levothyroxine Sodium
382
Jardiance
Empagliflozin
289
Rosuvastatin Calcium
202
Metformin Hcl
192
Mounjaro
Tirzepatide
180
Trulicity
Dulaglutide
135
Metformin Hcl Er
Metformin Hcl
121
Ozempic
Semaglutide
119
Humalog Kwikpen U-100
Insulin Lispro
113
Nateglinide
101

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How MERYL REICHMAN, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

MERYL REICHMAN, MD's 4,838 claims are above the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as REICHMAN.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MERYL REICHMAN, MD's specialty?
MERYL REICHMAN, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in FISHKILL, New York. Credentials: MD.
How much does MERYL REICHMAN, MD prescribe under Medicare Part D?
In 2023, MERYL REICHMAN, MD wrote 4,838 Medicare Part D claims totaling $2.5M in drug costs for 413 beneficiaries.
What is MERYL REICHMAN, MD's Medicare quality score?
MERYL REICHMAN, MD has a CMS MIPS Final Score of 59.9008/100 (Quality: 23.9172, Cost: 60.752). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MERYL REICHMAN, MD located?
MERYL REICHMAN, MD is located at 600 WESTAGE BUSINESS CTR DR, FISHKILL, NY, 12524. Phone: (845) 231-5600.
What is MERYL REICHMAN, MD's NPI number?
MERYL REICHMAN, MD's National Provider Identifier (NPI) is 1730296328, issued on 08/23/2006.
Does MERYL REICHMAN, MD prescribe more brand-name or generic drugs?
MERYL REICHMAN, MD's prescribing is 49% brand-name and 51% generic drugs by claim count, with $2.3M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does MERYL REICHMAN, MD prescribe most often?
Based on 2023 Medicare Part D data, MERYL REICHMAN, MD's most frequently prescribed drugs include Levothyroxine Sodium, Jardiance, Rosuvastatin Calcium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MERYL REICHMAN, MD accept Medicare?
MERYL REICHMAN, MD appears in CMS Medicare data with 4,838 Part D claims and 413 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MERYL REICHMAN, MD's credentials?
MERYL REICHMAN, MD's NPI is 1730296328 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology